Estée Lauder (NYSE: EL) closed fiscal 2026 with a Q4 that beat revenue and earnings estimates. The real story, however, is the forward look. Management raised its fiscal 2027 adjusted operating margin outlook to 12.7%–13.5%, up from a prior 12.5%–13.0%, while keeping organic sales growth guidance steady at 3%–5%.
That combination is the quarter's clearest signal. A margin raise without a sales raise. The Profit Recovery and Growth Plan (PRGP) is delivering ahead of schedule, generating $1.2 billion in gross benefits and eliminating 10,000 positions at the high end of targeted ranges. Full-year adjusted operating margin expanded 320 basis points to 11.2%. The company now expects another 150–230bps of expansion in fiscal 2027. Yet the reiterated top-line guide, even after organic growth accelerated to 5% in Q4, suggests management sees limits to how fast revenue can grow right now.
Q4 net sales rose 6% as reported to $3.63 billion, beating the $3.55 billion consensus. Organic growth hit 5%, with Skin Care up 7% and Fragrance up 10%. Adjusted diluted EPS of $0.39 more than quadrupled from $0.09 a year ago and topped the $0.32 estimate. Gross margin expanded 350 basis points to 75.5%, driven by PRGP operational efficiencies and a $38 million benefit from tariff refunds that partially offset $102 million in full-year tariff costs.
North America returned to growth in Q4. DECIEM's Abnormal Birthday Party campaign helped, as did an $18 million one-time benefit from gift card liability reversals. M·A·C's March 2026 launch in U.S. Sephora locations helped the makeup category improve its growth rate by 500bps versus the prior year, though makeup organic sales were still flat. Mainland China posted 7% organic growth, with the company citing value share gains in prestige beauty during key shopping moments.
The margin raise is credible. It is backed by structural cost reduction, not one-offs. The PRGP has fundamentally reshaped the cost base: non-consumer-facing expenses were flat for the full year despite higher employee incentive costs tied to better-than-expected performance. Consumer-facing investments rose 7% in Q4 and for the full year, funded by the PRGP savings. The company's guidance assumes continued operating leverage in non-consumer-facing expenses and modest gross margin expansion, even as it plans to increase capital expenditures to approximately 4% of sales from 3% in fiscal 2026.
Free cash flow surged to $1.32 billion from $670 million. The jump came from higher earnings and a $145 million reduction in capital expenditures. The company ended the year with $3.5 billion in cash, up from $2.92 billion, after paying $300 million in deferred consideration for the TOM FORD acquisition and $508 million in dividends.
The reiterated 3%–5% organic sales growth guide for fiscal 2027 is the cautious note. Management expects greater growth in the first half, driven by new product launches and easier travel retail comparisons, with a return to growth in makeup for the full year. But the company explicitly assumes "no deterioration in the geopolitical landscape or related impacts, including tariffs and consumer sentiment." That caveat matters. Tariffs cost $102 million in fiscal 2026, and while refunds provided some relief, the tariff environment remains uncertain. The Middle East conflict, which had a dilutive impact of $0.05 on Q4 adjusted EPS, is not expected to materially affect fiscal 2027, but that assumption carries its own risk.
Estée Lauder's restructuring is working faster and better than planned, creating genuine operating leverage. The margin expansion is being achieved against a top-line growth rate that, while positive, remains modest for a company with this brand portfolio. The question for fiscal 2027 is whether the reinvestment funded by PRGP savings can accelerate organic growth toward the high end of the 3%–5% range, or whether the margin improvement comes at the expense of the revenue acceleration the company needs to justify its current valuation.